The TFRI-MOHCCN Technology Development Awards provides funding to projects to develop additional profiling technologies that would generate data compatible with precision oncology and could be applied to a section of the MOHCCN Gold Cohort.
When autocomplete results are available use up and down arrows to review and enter to select.
The Princess Margaret Cancer Consortium coalesces the expertise and efforts of clinicians, pathologists, software developers and data and translational scientists to help accelerate precision medicine...